HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Hölscher Selected Research

gastric inhibitory polypeptide (3-42)

5/2012Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Hölscher Research Topics

Disease

67Alzheimer Disease (Alzheimer's Disease)
04/2024 - 01/2005
38Parkinson Disease (Parkinson's Disease)
02/2024 - 04/2014
38Type 2 Diabetes Mellitus (MODY)
01/2024 - 06/2008
34Inflammation (Inflammations)
02/2024 - 01/2010
20Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 06/2008
15Amyloid Plaque
01/2020 - 04/2011
11Insulin Resistance
01/2022 - 05/2012
10Cognitive Dysfunction
10/2022 - 07/2013
6Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 10/2016
5Gliosis
10/2022 - 09/2006
5Neuroinflammatory Diseases
01/2022 - 02/2017
5Obesity
07/2020 - 05/2012
5Neuroblastoma
01/2020 - 02/2014
4Disease Progression
01/2024 - 01/2017
4Stroke (Strokes)
01/2022 - 10/2012
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2024 - 10/2012
3Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2016
3Memory Disorders (Memory Loss)
01/2020 - 01/2013
3Central Nervous System Diseases (CNS Diseases)
01/2019 - 10/2016
2Infarction (Infarctions)
01/2021 - 11/2019
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2019 - 01/2016
2Status Epilepticus (Complex Partial Status Epilepticus)
01/2019 - 01/2018
2Hypokinesia (Bradykinesia)
02/2016 - 12/2015
1Huntington Disease (Huntington's Disease)
01/2024
1Giant Axonal Neuropathy
01/2024
1Glucose Metabolism Disorders
12/2023
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2022
1Ischemic Stroke
01/2022
1Non-alcoholic Fatty Liver Disease
06/2021
1Neurologic Manifestations (Neurological Manifestations)
01/2021

Drug/Important Bio-Agent (IBA)

51Glucagon-Like Peptide 1 (GLP 1)IBA
04/2024 - 06/2008
30Insulin (Novolin)FDA Link
01/2022 - 06/2008
29Neuroprotective AgentsIBA
02/2024 - 01/2013
22LiraglutideFDA Link
04/2024 - 04/2011
21IncretinsIBA
01/2021 - 12/2009
16Amyloid (Amyloid Fibrils)IBA
01/2022 - 09/2006
15Peptides (Polypeptides)IBA
12/2022 - 06/2008
14Glucose (Dextrose)FDA LinkGeneric
01/2024 - 01/2011
141- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2022 - 10/2015
13Hormones (Hormone)IBA
01/2020 - 09/2010
12gastric inhibitory polypeptide receptorIBA
01/2023 - 01/2016
11Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2023 - 04/2011
8Exenatide (Byetta)FDA Link
01/2021 - 04/2014
5Proteins (Proteins, Gene)FDA Link
01/2024 - 02/2012
5semaglutideIBA
12/2023 - 10/2018
5Dopamine (Intropin)FDA LinkGeneric
01/2023 - 01/2020
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023 - 02/2014
5CytokinesIBA
01/2023 - 01/2019
5Glucagon-Like Peptide-1 ReceptorIBA
01/2021 - 12/2009
5Peptide Hydrolases (Proteases)FDA Link
01/2020 - 10/2012
5lixisenatideIBA
01/2020 - 02/2014
4Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2013
4OxyntomodulinIBA
09/2022 - 10/2015
4Amyloid beta-PeptidesIBA
09/2022 - 01/2005
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2024 - 02/2017
3Cholecystokinin (Pancreozymin)IBA
02/2024 - 01/2022
3SynucleinsIBA
01/2022 - 01/2019
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2022 - 10/2017
3Autophagy-Related ProteinsIBA
08/2021 - 10/2018
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2020 - 10/2018
3EnzymesIBA
01/2018 - 01/2011
2Neurotransmitter Agents (Neurotransmitter)IBA
02/2024 - 12/2022
2magnololIBA
12/2023 - 04/2020
2alpha-SynucleinIBA
01/2023 - 01/2020
2GhrelinIBA
12/2022 - 01/2020
2Oxidopamine (6 Hydroxydopamine)IBA
01/2022 - 01/2017
2dehydroabietic acidIBA
06/2021 - 07/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 05/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2019
2Messenger RNA (mRNA)IBA
07/2020 - 10/2017
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2020 - 04/2020
2Pilocarpine (Ocusert)FDA LinkGeneric
01/2019 - 01/2018
2Fatty Acids (Saturated Fatty Acids)IBA
10/2018 - 01/2016
2Glucagon Receptors (Glucagon Receptor)IBA
01/2018 - 10/2016
2Therapeutic UsesIBA
01/2018 - 01/2017
2Blood Glucose (Blood Sugar)IBA
01/2018 - 09/2012
2Glucagon-Like Peptides (Enteroglucagon)IBA
11/2017 - 01/2013
2Ala2-GIP-Glu-PALIBA
02/2017 - 02/2016
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2017 - 10/2016
2geniposideIBA
12/2015 - 01/2015
2Congo RedIBA
11/2014 - 02/2012
2Presenilin-1IBA
02/2014 - 02/2012
2Insulin ReceptorIBA
10/2012 - 01/2010
1Sirtuin 1IBA
12/2023
1Competitive Endogenous RNAIBA
08/2023
1Long Noncoding RNAIBA
08/2023
1Glutamic Acid (Glutamate)FDA Link
12/2022
1Serotonin (5 Hydroxytryptamine)IBA
12/2022
1Aminobutyrates (Aminobutyric Acid)IBA
12/2022
1Beclin-1IBA
10/2022
1mitochondrial calcium uniporterIBA
10/2022
1aducanumabIBA
01/2022
1Glucagon (Glukagon)FDA Link
01/2022
1ApomorphineFDA Link
01/2022
1Peptide Hormones (Polypeptide Hormones)IBA
01/2022
1IronIBA
06/2021
1Lipid PeroxidesIBA
06/2021

Therapy/Procedure

6Therapeutics
10/2022 - 10/2016
3Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2017 - 12/2015
1Mechanical Thrombolysis
01/2022